JAK inhibitors for the Management of Atopic Dermatitis (AD)

home / peer-exchange / jak-inhibitors-for-the-management-of-atopic-dermatitis-ad

Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.

© 2023 MJH Life Sciences

All rights reserved.